IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Matrix Capital Management Company, LP

Q1 2025 Holdings

Filed 2025-05-14 | 4 holdings | $347.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Globalfoundries Inc(GFS)ORDINARY SHARESG39387108$257.1M6,964,95274.0%
Aura Biosciences Inc(AURA)COM05153U107$40.6M6,922,87011.7%
Maze Therapeutics Inc(MAZE)COM578784100$27.4M2,486,1847.9%
Zentalis Pharmaceuticals Inc(ZNTL)COM98943L107$22.2M13,959,9736.4%